logo
Select company
Select metric
$ -202.9MConsolidated Income
VS
Market
7
Sector
10
Industry
13
History
24
$ 3.7Close
$ 1.66 - $ 3.9 52-Week Range
Ticker Information

Ticker

NUVB

Company Name

NUVATION BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

NUVATION BIO INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NUVB - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -202.9M
3/31/2025$ -606.38M
12/31/2024$ -567.94M
9/30/2024$ -532.28M
6/30/2024$ -510.72M
3/31/2024$ -68.87M
12/31/2023$ -75.8M
9/30/2023$ -82.86M
6/30/2023$ -90.41M
3/31/2023$ -104.63M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVATION BIO INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -41.66M.
  • Over the past 5 years, NUVATION BIO INC's average Cons. Inc. has been $ -194.15M.
  • The median Cons. Inc. for NUVATION BIO INC during this period was $ -96.84M
  • NUVATION BIO INC reached its highest Cons. Inc. over the past 5 years at $ -41.66M.
  • The lowest Cons. Inc. recorded by NUVATION BIO INC in the same timeframe $ -606.38M

NUVATION BIO INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
QURE : UNIQURE NV $ -199MZBIO : ZENAS BIOPHARMA INC $ -177.01MABUS : ARBUTUS BIOPHARMA CORP $ -54.25MIMNM : IMMUNOME INC $ -212.39MVIR : VIR BIOTECHNOLOGY INC $ -550.23MTSHA : TAYSHA GENE THERAPIES INC $ -92.72MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MRLAY : RELAY THERAPEUTICS INC $ -311.55MBCYC : BICYCLE THERAPEUTICS PLC $ -242.36MTNGX : TANGO THERAPEUTICS INC $ -145.57M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

NUVB - Consolidated Income, Last 5 years

$ -606.38M

Minimum

Mar 31, 2025

$ -41.66M

Maximum

Dec 31, 2020

$ -194.15M

Average

$ -96.84M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.12M with a standard deviation of $ 116.68M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.12M
median$ -2.09M
std$ 116.68M